Clinical Trials Browser

Phase 2 × Uterine Cervical Dysplasia × 90 days × Clear all

NCT04712851 2026-03-10

Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia

Phase 2 Recruiting

Uterine Cervical Dysplasia

NCT07454915 2026-03-09

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Phase 2 Not yet recruiting

Uterine Cervical Dysplasia